Erie Indemnity
ERIE Nasdaq Insurance Brokers Financials FY2016βFY2025
Erie Indemnity's revenue rose 7.2% to $4.1 billion in fiscal 2025. Its operating margin was 17.6%, down from 17.8% a year earlier. Free cash flow was $571 million, up 17.4%. It paid out $254 million in dividends and buybacks, 45% of free cash flow.
About these figures. Erie Indemnity reports earnings per share and share counts separately for its Class A and Class B shares, which the SEC's company-level data leaves out, so per-share figures are left blank.
What Erie Indemnity does
No business description yet.
- Legal name
- ERIE INDEMNITY COMPANY
- Fiscal year ends
- December 31, 2025
- Latest annual report
- β
- Accession Β· CIK
- 0001628280-26-010666
0000922621
Revenue and margins
Erie Indemnity had $4.1B of revenue in fiscal 2025, up 7.2% on the year before.
Net income and earnings per share
Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was $571M in fiscal 2025, 14.0% of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
Erie Indemnity returned $254M to shareholders in fiscal 2025, 45% of free cash flow. The diluted share count rose 0.0%.
Value Erie Indemnity yourself
Change the assumptions and see what they imply per share. These are models, not forecasts or price targets β the answer depends entirely on what you put in.
Discounted cash flow
Value per share
β
Adds net cash of $380M and divides by 0.0M diluted shares. Ten years of cash flows plus a terminal value, discounted to today.
Balance sheet
Cash, debt and the ratios that show how comfortably Erie Indemnity can carry it.
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | $222M | $166M | $226M | $343M | $380M |
| Debt incl. finance leases | $93.8M | $0.0M | $0.0M | $0.0M | $0.0M |
| Net debt / EBITDA | β0.4x | β0.4x | β0.4x | β0.5x | β0.5x |
| Debt / equity | 0.1x | 0.0x | 0.0x | 0.0x | 0.0x |
| Interest coverage | 77.0x | 187.3x | β | β | β |
| Current ratio | 1.2x | 1.2x | 1.3x | 1.4x | 1.3x |
| Quick ratio | 1.2x | 1.2x | 1.3x | 1.4x | 1.3x |
| Total assets | $2.2B | $2.2B | $2.5B | $2.9B | $3.4B |
| Total liabilities | $900M | $791M | $809M | $901M | $1.1B |
| Shareholders' equity | $1.3B | $1.4B | $1.7B | $2.0B | $2.3B |
| Net debt (β = net cash) | β$128M | β$166M | β$226M | β$343M | β$380M |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$1.4M
1 insider
Sold, 12 months
$0.1M
1 insider
Of sales under plans
0%
$0.0M
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8β9 is strong, 0β2 weak.
| Test | FY23 | FY24 | FY25 |
|---|---|---|---|
| Net income is positive | β | β | β |
| Cash from operations is positive | β | β | β |
| Return on assets rose | β | β | β |
| Cash from operations exceeds net income | β | β | β |
| Debt fell relative to assets | β | β | β |
| Current ratio rose | β | β | β |
| Share count didn't rise | β | β | β |
| Gross margin rose | β | β | β |
| Revenue rose relative to assets | β | β | β |
| F-score | β / 9 | β / 9 | β / 9 |
| Accruals ratio | 2.8% | β0.4% | β4.1% |
| Altman Z'' | 7.86 | 8.24 | 7.53 |
Similar companies
Each company's latest fiscal year. Fiscal years end in different months, so periods don't line up exactly.
| Company | Market cap | Growth | Op. margin | FCF margin | ROIC | P/E | F-score | |
|---|---|---|---|---|---|---|---|---|
| Erie Indemnity ERIE | β | 7.2% | 17.6% | 14.0% | 31.8% | β | β | |
| Ryan Specialty RYAN | β | 21.3% | 16.2% | 21.0% | 8.7% | β | β | Compare β |
| Brown & Brown BRO | $24.4B | 22.8% | β | 23.4% | 9.1% | 23.0x | 4 | Compare β |
| Willis Towers Watson WTW | $30.6B | β2.2% | 23.0% | 15.9% | 12.8% | 20.1x | 7 | Compare β |
| Arthur J. Gallagher AJG | $68.8B | 20.7% | β | 12.8% | 9.9% | 44.5x | 3 | Compare β |
10 years of figures
US$ millions unless stated. Hover a ratio's name for its definition.
| Fiscal year | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||
| Revenue | $1.6B | $1.7B | $2.4B | $2.5B | $2.5B | $2.6B | $2.8B | $3.3B | $3.8B | $4.1B |
| Operating income | $294M | $290M | $344M | $357M | $338M | $318M | $376M | $520M | $677M | $717M |
| Interest expense | $0.1M | $1.2M | $2.5M | $0.9M | $0.7M | $4.1M | $2.0M | $0.0M | $0.0M | β |
| Pretax income | $320M | $316M | $371M | $397M | $369M | $376M | $377M | $562M | $757M | $711M |
| Income tax | $110M | $119M | $83.1M | $79.9M | $75.2M | $78.5M | $77.9M | $116M | $157M | $151M |
| Net income | $210M | $197M | $288M | $317M | $293M | $298M | $299M | $446M | $600M | $559M |
| Cash flow | ||||||||||
| Cash from operations | $254M | $197M | $264M | $365M | $343M | $403M | $366M | $381M | $611M | $687M |
| Capital expenditure | $25.2M | $28.9M | $56.3M | $102M | $55.5M | $149M | $67.2M | $92.6M | $125M | $116M |
| Free cash flow | $229M | $168M | $207M | $262M | $287M | $254M | $299M | $289M | $486M | $571M |
| Depreciation and amortization | $15.1M | $14.8M | $13.4M | $16.8M | $21.2M | $37.2M | $45.9M | $47.4M | $56.5M | $69.5M |
| Acquisitions | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| Share buybacks | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| Dividends paid | $136M | $146M | $157M | $168M | $273M | $193M | $207M | $222M | $238M | $254M |
| Dividends and buybacks | $136M | $146M | $156M | $168M | $273M | $193M | $207M | $222M | $238M | $254M |
| Balance sheet | ||||||||||
| Cash and short-term investments | $189M | $216M | $669M | $370M | $179M | $222M | $166M | $226M | $343M | $380M |
| Total debt | $24.8M | $74.7M | $99.7M | $97.8M | $95.9M | $93.8M | $0.0M | $0.0M | $0.0M | $0.0M |
| Finance lease liabilities | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| Current assets | $666M | $802M | $1.2B | $891M | $732M | $764M | $779M | $930M | $1.1B | $1.2B |
| Current liabilities | $470M | $510M | $547M | $588M | $628M | $631M | $665M | $709M | $803M | $946M |
| Inventory | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| Total assets | $1.5B | $1.7B | $1.8B | $2.0B | $2.1B | $2.2B | $2.2B | $2.5B | $2.9B | $3.4B |
| Total liabilities | $732M | $809M | $805M | $883M | $929M | $900M | $791M | $809M | $901M | $1.1B |
| Shareholders' equity | $817M | $857M | $974M | $1.1B | $1.2B | $1.3B | $1.4B | $1.7B | $2.0B | $2.3B |
| Margins | ||||||||||
| Operating margin | 18.4% | 17.2% | 14.5% | 14.4% | 13.3% | 12.1% | 13.3% | 15.9% | 17.8% | 17.6% |
| EBITDA margin | 19.3% | 18.0% | 15.0% | 15.1% | 14.2% | 13.5% | 14.9% | 17.4% | 19.3% | 19.3% |
| Net margin | 13.2% | 11.6% | 12.1% | 12.8% | 11.6% | 11.3% | 10.5% | 13.7% | 15.8% | 13.8% |
| FCF margin | 14.4% | 9.9% | 8.7% | 10.6% | 11.3% | 9.6% | 10.5% | 8.8% | 12.8% | 14.0% |
| Returns | ||||||||||
| Return on capital | β | 26.5% | 47.7% | 45.1% | 27.4% | 21.7% | 23.9% | 30.4% | 34.8% | 31.8% |
| Return on capital employed | 28.8% | 26.0% | 28.9% | 26.9% | 23.2% | 20.5% | 23.6% | 31.2% | 35.2% | 31.9% |
| Return on equity | 26.5% | 23.5% | 31.5% | 30.1% | 25.3% | 23.5% | 21.4% | 28.7% | 32.9% | 26.2% |
| Return on assets | 14.2% | 12.3% | 16.7% | 16.7% | 14.2% | 13.7% | 13.3% | 18.9% | 22.4% | 17.9% |
| Growth | ||||||||||
| Revenue growth | 6.1% | 6.0% | 40.8% | 4.0% | 2.4% | 3.8% | 7.8% | 15.1% | 16.1% | 7.2% |
| Net income growth | 20.4% | β6.4% | 46.3% | 9.9% | β7.4% | 1.6% | 0.2% | 49.4% | 34.6% | β6.8% |
| FCF growth | β | β26.6% | 23.2% | 26.6% | 9.4% | β11.5% | 17.7% | β3.5% | 68.6% | 17.4% |
| Financial health | ||||||||||
| Net debt / EBITDA | β0.5x | β0.5x | β1.6x | β0.7x | β0.2x | β0.4x | β0.4x | β0.4x | β0.5x | β0.5x |
| Debt / equity | 0.0x | 0.1x | 0.1x | 0.1x | 0.1x | 0.1x | 0.0x | 0.0x | 0.0x | 0.0x |
| Interest coverage | 2,906.1x | 234.5x | 140.0x | 417.5x | 462.6x | 77.0x | 187.3x | β | β | β |
| Current ratio | 1.4x | 1.6x | 2.1x | 1.5x | 1.2x | 1.2x | 1.2x | 1.3x | 1.4x | 1.3x |
| Quick ratio | 1.4x | 1.6x | 2.1x | 1.5x | 1.2x | 1.2x | 1.2x | 1.3x | 1.4x | 1.3x |
| Capital allocation | ||||||||||
| Capex / revenue | 1.6% | 1.7% | 2.4% | 4.1% | 2.2% | 5.7% | 2.4% | 2.8% | 3.3% | 2.8% |
| Payouts / FCF | 59.4% | 86.7% | 75.5% | 63.9% | 95.1% | 75.9% | 69.2% | 76.8% | 48.8% | 44.5% |
| Quality scores | ||||||||||
| Altman Z'' | 7.6 | 7.6 | 9.0 | 7.4 | 6.4 | 6.5 | 7.1 | 7.9 | 8.2 | 7.5 |
| Accruals ratio | β3.0% | β0.0% | 1.4% | β2.5% | β2.4% | β4.8% | β3.0% | 2.8% | β0.4% | β4.1% |
Source: SEC EDGAR XBRL filings (CIK 0000922621). Data updated October 9, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β not investment advice. Check the original filings before relying on any figure.